The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray (Q37433739)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2005

Language	Label	Description	Also known as
English	The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray	scientific article published on August 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

The usefulness of CDX-2 for differentiating primary and metastatic ovarian carcinoma: an immunohistochemical study using a tissue microarray (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

immunohistochemistry

1 reference

based on heuristic

inferred from title

ovarian carcinoma

1 reference

based on heuristic

inferred from title

author name string

Mi Jin Kim

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2005

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Journal of Korean Medical Science

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

20

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

643-648

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 January 2005

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

CDX-2, a new marker for adenocarcinoma of gastrointestinal origin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

23 August 2017

Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

23 August 2017

Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

23 August 2017

Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

23 August 2017

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

23 August 2017

An intestine-specific homeobox gene regulates proliferation and differentiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

23 August 2017

Human alveolar macrophage-56 and carcinoembryonic antigen monoclonal antibodies in the differential diagnosis between primary ovarian and metastatic gastrointestinal carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

14 September 2017

The role of the HER-2/neu oncogene in gynecologic cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

28 September 2017

Metastatic ovarian carcinoma of large intestinal origin simulating primary ovarian carcinoma. A clinicopathologic study of 25 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

26 June 2018

The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

2 September 2018

CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

2 September 2018

Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

2 September 2018

HER-2/neu expression in ovarian clear cell carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

2 September 2018

Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

2 September 2018

Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

2 September 2018

Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2782162

2 September 2018

Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16100458

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16100458

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/16100458

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CDX-2 Homeobox Gene Expression Is a Reliable Marker of Colorectal Adenocarcinoma Metastases to the Lungs

1 reference

https://pubmed.ncbi.nlm.nih.gov/16100458

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16100458

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/16100458

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/16100458

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries

1 reference

https://pubmed.ncbi.nlm.nih.gov/16100458

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intestinal adenocarcinomas metastatic to the ovaries. A clinicopathologic evaluation of 22 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16100458

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary

1 reference

https://pubmed.ncbi.nlm.nih.gov/16100458

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary

1 reference

https://pubmed.ncbi.nlm.nih.gov/16100458

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16100458

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3346/JKMS.2005.20.4.643

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37433739&oldid=1870810530"